Literature DB >> 4282920

Superiority of intravenously administered BCG and BCG cell walls in protecting rhesus monkeys (Macaca mulatta) against airborne tuberculosis.

R L Anacker, W Brehmer, W R Barclay, W R Leif, E Ribi, J H Simmons, A W Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4282920

Source DB:  PubMed          Journal:  Z Immunitatsforsch Exp Klin Immunol        ISSN： 0300-872X


× No keyword cloud information.
  11 in total

1.  Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.

Authors:  S A Sharpe; H McShane; M J Dennis; R J Basaraba; F Gleeson; G Hall; A McIntyre; K Gooch; S Clark; N E R Beveridge; E Nuth; A White; A Marriott; S Dowall; A V S Hill; A Williams; P D Marsh
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

Review 2.  BCG vaccination strategies against tuberculosis: updates and perspectives.

Authors:  Mengjin Qu; Xiangmei Zhou; Hao Li
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

Review 3.  Research and development of new tuberculosis vaccines: a review.

Authors:  Lewis K Schrager; Rebecca C Harris; Johan Vekemans
Journal:  F1000Res       Date:  2018-11-01

4.  Mycobacterium tuberculosis infection in rhesus monkeys (Macaca mulatta) and evaluation of ESAT-6 and CFP10 as immunodiagnostic antigens.

Authors:  Fangui Min; Yu Zhang; Jinchun Pan; Jing Wang; Wen Yuan
Journal:  Exp Anim       Date:  2013

5.  Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.

Authors:  S Sharpe; A White; C Sarfas; L Sibley; F Gleeson; A McIntyre; R Basaraba; S Clark; G Hall; E Rayner; A Williams; P D Marsh; M Dennis
Journal:  Tuberculosis (Edinb)       Date:  2016-10-08       Impact factor: 3.131

Review 6.  The Humoral Immune Response to BCG Vaccination.

Authors:  Rachel Tanner; Bernardo Villarreal-Ramos; H Martin Vordermeier; Helen McShane
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

Review 7.  Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics.

Authors:  Ana B Enriquez; Angelo Izzo; Shannon M Miller; Erica L Stewart; Robert N Mahon; Daniel J Frank; Jay T Evans; Jyothi Rengarajan; James A Triccas
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 8.786

Review 8.  The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.

Authors:  Allison N Bucsan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Pathog Dis       Date:  2019-06-01       Impact factor: 3.166

Review 9.  Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology.

Authors:  Stefan H E Kaufmann
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

10.  Prevention of tuberculosis in macaques after intravenous BCG immunization.

Authors:  Mario Roederer; JoAnne L Flynn; Robert A Seder; Patricia A Darrah; Joseph J Zeppa; Pauline Maiello; Joshua A Hackney; Marc H Wadsworth; Travis K Hughes; Supriya Pokkali; Phillip A Swanson; Nicole L Grant; Mark A Rodgers; Megha Kamath; Chelsea M Causgrove; Dominick J Laddy; Aurelio Bonavia; Danilo Casimiro; Philana Ling Lin; Edwin Klein; Alexander G White; Charles A Scanga; Alex K Shalek
Journal:  Nature       Date:  2020-01-01       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.